Get started Log in

CNTX — Context Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Brief: Context Therapeutics Reports Q1 2022 Operating And Financial Results
11/05/2022 21:48
Brief: Context Therapeutics Reports Full Year 2021 Financial Results
23/03/2022 20:23
Brief: Context Therapeutics Files For Resale Of Up To 10 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
10/12/2021 21:52
Context Therapeutics up after drug shows promise in breast cancer study
10/12/2021 11:09
Brief: Context Therapeutics Announces Positive Data From ONA-XR in Early Breast Cancer At 2021 San Antonio Breast Cancer Symposium
09/12/2021 23:03
Brief: Context Therapeutics Reports Third Quarter 2021 Operating And Financial Results
02/12/2021 21:05
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:47 AM
01/12/2021 16:47
Brief: Context Therapeutics Inc. Appoints Jennifer Minai-Azary As Chief Financial Officer
01/11/2021 20:50
Brief: Context, Wisconsin Oncology Network Announce First Patient Dosed In Phase 2 Trial Of ONA-XR In Metastatic Breast Cancer
27/10/2021 13:27
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:56 AM
22/10/2021 14:57
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
20/10/2021 08:59